Sanovel Iia San Ve Tic competitive analysis

Explore patent oppositions filed by Sanovel Iia San Ve Tic against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 25, 2026
Patent NumberTitleApplicantOpposition Date
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISDec 7, 2023
Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIMJun 13, 2023

Latest PTAB cases involving Sanovel Iia San Ve Tic

Discover the latest PTAB cases involving Sanovel Iia San Ve Tic, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Sanovel Iia San Ve Tic with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 25, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SANOVEL IIA SAN VE TIC2 - - -
BOEHRINGER INGELHEIM3321789
NOVARTIS6526 - 21